Breast cancer characteristics and survival differences between Maori, Pacific and other New zealand women included in the quality audit program of breast surgeons of Australia and New Zealand

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 6, 2015, Pages 2465-2472

  Campbell, Ian ^a   Scott, Nina ^b   Seneviratne, Sanjeewa ^a   Kollias, James ^c,d   Walters, David ^c   Taylor, Corey ^e   Roder, David ^f  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Waikato District Health Board   (New Zealand)

^c National Breast Cancer Audit Steering Committee Breast Surgeons of Australia and New Zealand   (United States)

^d ROYAL ADELAIDE HOSPITAL   (Australia)

^e Breast Surgeons of Australia and New Zealand Quality Audit   (Australia)

^f UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Australia and New Zealand; Breast cancer; Ethnicity; Risk factors; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGED; BREAST TUMOR; CANCER STAGING; CLINICAL AUDIT; COMORBIDITY; ENZYME IMMUNOASSAY; ETHNIC GROUP; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; LUNG CARCINOMA; METABOLISM; MIDDLE AGED; MORTALITY; NEW ZEALAND; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; REGISTER; RISK FACTOR; SOCIOECONOMICS; SURGEON; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CLINICAL AUDIT; COMORBIDITY; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM STAGING; NEW ZEALAND; PROGNOSIS; QUALITY ASSURANCE, HEALTH CARE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; RISK FACTORS; SOCIOECONOMIC FACTORS; SURGEONS; SURVIVAL RATE;

EID: 84929191048     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.6.2465     Document Type: Article

References (25)

1. Armitage P, Berry G (1987). Statistical methods in medical research. Oxford, Blackwell Scientific Publications.
2. ASERNIP-S (2005). The National Breast Cancer Audit. Process for Managing Outliers In 'Breast Cancer Surgery'. Adelaide, Royal Australasian College of Surgeons.
3. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries (2012). Cancer in Australia: an overview, 2012. Cancer series no.74. Cat. No. CAN 70. Canberra, Australian Institute of Health and Welfare.
4. Campbell ID, Scott N, Seneviratne S, et al (2014). Breast cancer survival in New Zealand women. ANZ J Surg. [In press]
5. Cancer Research UK (2013). Cancer survival statistics. London, Cancer research UK.
6. Coleman MP, Forman D, Bryant H, et al (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International cancer benchmarking partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38.
7. DeVita VT, Lawrence TS, Rosenberg SA, DePinho RA, Weinberg RA (2008). Cancer: Principles and Practice of Oncology. 8th Edition. Philadelphia, Lippincott, Williams and Wilkins.
8. Fine JP, Gray RJ (1999). A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc, 94, 496-509.
9. Howlader N, Noone AM, Krapcho M, et al (2013). SEER cancer statistics review, 1975-2010. Bethesda MD, National Cancer Institute.
10. Jeffreys M, Stevanovic V, Tobias M, et al (2005). Ethnic inequalities in cancer survival in New Zealand: linkage study. Am J Public Health, 95, 834-7.
11. New Zealand Ministry of Health (2007). Epidemiology of HER2 positive breast cancer in New Zealand. Wellington, Ministry of Health. http://www.pharmac.govt.nz/2007/06/13/290607c.pdf/text
12. New Zealand Ministry of Health (2012a). Cancer patient survival. Change over time update: covering the period 1994 to 2009. Wellington, Ministry of Health.
13. New Zealand Ministry of Health (2012b). Cancer: New Registrations and Deaths 2009. Wellington, Ministry of Health.
14. New Zealand Ministry of Health (2013). National Health Index. Wellington, Ministry of Health.
15. NHMRC National Breast Cancer Centre (2001). Clinical practice guidelines for the management of early breast cancer: Second edition. Canberra, NHMRC.
16. Roder D, Wang JX, Zorbas H, Kollias J, Maddern G (2010). Survival from breast cancers managed by surgeons participating in the national breast cancer audit of the royal Australasian college of surgeons. ANZ J Surg, 80, 776-80.
17. Rush EC, Plank LD, Mitchelson E, Laulau MS (2002). Central obesity and risk for type 2 diabetes in Maori, Pacific, and European young men in New Zealand. Food Nutr Bull, 23, 82-6.
18. Salmond C, Crampton P, Atkinson J (2007). NZDep2006 Index of Deprivation. Wellington, Department of Public Health, University of Otago.
19. Sarfati D, Blakely T, Pearce N (2010). Measuring cancer survival in populations: relative survivals vs cancer-specific survival. Int J Epidemiol, 39, 598-610.
20. Soeberg M, Blakely T, Sarfati D, et al (2012). Cancer trends: Trends in cancer survival by ethnic and socio-economic group. New Zealand 1991-2004. wellington, university of otago and ministry of health.
21. South Australian Cancer Registry (1999). Epidemiology of cancer in South Australia. incidence, mortality and survival 1977 to 1996. Incidence and mortality 1996. Adelaide, Openbook Publ.
22. South Australian Cancer Registry (2007). Cancer in South Australia 2004, with incidence projections to 2007. Adelaide, Department of Health.
23. STATA (2012). Data analysis and statistical software. Version 12. college station, Texas: StataCorp LP.
24. Utada M, Ohno Y, Shimizu S, et al (2012). Comparison between overall, cause-specific, and relative survival rates based on data from a population-based cancer registry. Asian Pac J Cancer Prev, 13, 5681-5.
25. Wang J, Boult M, Roder D, et al (2008). Commentary: how surgical audits can be used to promote uptake of surgical evidence. ANZ J Surg, 78, 437-8.